Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Evans

Showing results (91-100 of 208) with videos related to

Pageof 21
Sort By:
Cancer Research|January 2, 2009
Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancerJoy C Yang, Joon-ha Ok, J Erik Busby, et al.
Rare Tumors|July 27, 2018
Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia-telangiectasiaSean James Judge, Trevor A Plescia, Cyrus P Bateni, et al.
European Urology|November 14, 2017
Genomic Markers in Prostate Cancer Decision MakingVito Cucchiara, Matthew R Cooperberg, Marc Dall'Era, et al.
The Prostate|June 18, 2011
RhoGDIα suppresses growth and survival of prostate cancer cellsYezi Zhu, Ramakumar Tummala, Chengfei Liu, et al.
American Journal of Clinical and Experimental Urology|September 13, 2019
Wntless promotes cellular viability and resistance to enzalutamide in castration-resistant prostate cancer cellsAlan P Lombard, Chengfei Liu, Cameron M Armstrong, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 25, 2018
Local treatment for metastatic prostate cancer: A systematic reviewDerya Tilki, Raisa S Pompe, Marco Bandini, et al.
AJR. American Journal of Roentgenology|September 19, 2019
Utility of Intraprocedural Contrast-Enhanced CT in Ablation of Renal MassesArleen Grewal, Satinderpal Singh Khera, John P McGahan, et al.
Molecular Cancer Therapeutics|July 30, 2021
Activation of the <i>ABCB1</i> Amplicon in Docetaxel- and Cabazitaxel-Resistant Prostate Cancer CellsAlan P Lombard, Wei Lou, Cameron M Armstrong, et al.
Molecular Cancer Therapeutics|July 13, 2017
ABCB1 Mediates Cabazitaxel-Docetaxel Cross-Resistance in Advanced Prostate CancerAlan P Lombard, Chengfei Liu, Cameron M Armstrong, et al.
Molecular Cancer Therapeutics|November 13, 2019
Therapeutic Targeting of MDR1 Expression by RORγ Antagonists Resensitizes Cross-Resistant CRPC to Taxane via Coordinated Induction of Cell Death ProgramsYongqiang Wang, Zenghong Huang, Christopher Z Chen, et al.
Pageof 21

Showing results (91-100 of 208) with videos related to

Sort By:
Pageof 21
Cancer Research|January 2, 2009
Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancerJoy C Yang, Joon-ha Ok, J Erik Busby, et al.
Rare Tumors|July 27, 2018
Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia-telangiectasiaSean James Judge, Trevor A Plescia, Cyrus P Bateni, et al.
European Urology|November 14, 2017
Genomic Markers in Prostate Cancer Decision MakingVito Cucchiara, Matthew R Cooperberg, Marc Dall'Era, et al.
The Prostate|June 18, 2011
RhoGDIα suppresses growth and survival of prostate cancer cellsYezi Zhu, Ramakumar Tummala, Chengfei Liu, et al.
American Journal of Clinical and Experimental Urology|September 13, 2019
Wntless promotes cellular viability and resistance to enzalutamide in castration-resistant prostate cancer cellsAlan P Lombard, Chengfei Liu, Cameron M Armstrong, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 25, 2018
Local treatment for metastatic prostate cancer: A systematic reviewDerya Tilki, Raisa S Pompe, Marco Bandini, et al.
AJR. American Journal of Roentgenology|September 19, 2019
Utility of Intraprocedural Contrast-Enhanced CT in Ablation of Renal MassesArleen Grewal, Satinderpal Singh Khera, John P McGahan, et al.
Molecular Cancer Therapeutics|July 30, 2021
Activation of the <i>ABCB1</i> Amplicon in Docetaxel- and Cabazitaxel-Resistant Prostate Cancer CellsAlan P Lombard, Wei Lou, Cameron M Armstrong, et al.
Molecular Cancer Therapeutics|July 13, 2017
ABCB1 Mediates Cabazitaxel-Docetaxel Cross-Resistance in Advanced Prostate CancerAlan P Lombard, Chengfei Liu, Cameron M Armstrong, et al.
Molecular Cancer Therapeutics|November 13, 2019
Therapeutic Targeting of MDR1 Expression by RORγ Antagonists Resensitizes Cross-Resistant CRPC to Taxane via Coordinated Induction of Cell Death ProgramsYongqiang Wang, Zenghong Huang, Christopher Z Chen, et al.
Pageof 21